Description

Bauer et al developed equations for predicting outcomes prior to radical prostatectomy in men with prostate cancer. The authors are from Walter Reed Medical Center and the Uniformed Services University of Health Sciences.


 

Patient selection: prostate cancer with clinical Stage 1 or 2

 

Parameters:

(1) sigmoidal transformation for the PSA (see Chapter 16)

(2) maximum preoperative Gleason score (worst)

(3) clinical tumor stage

(4) race

Parameter

Finding

Points

tumor stage

not that stage

0

 

that stage

1

race

Black (Afro-American)

1

 

other (Asian, Hispanic, White)

0

 

X for recurrence risk =

= (0.47 * (points for race)) + (0.14 * (sigmoidal transformation of the PSA)) + (0.13 * (maximum Gleason score)) + (1.03 if Stage 1c) + (1.55 if Stage 2b or 2c)

 

risk score for recurrence =

= EXP(X)

 

Risk Score for Recurrence

Risk for Recurrence

< 8.0

low

8.0 to 40.0

intermediate

> 40.0

high

 

Y for extracapsular extension at surgery =

= (0.18 * (points for race)) + (0.15 * (sigmoidal transformation of the PSA)) + (0.31 * (maximum Gleason score)) + (0.16 if Stage 1c) + (0.38 if Stage 2b or 2c) - 2.47

 

probability of extracapsular extension =

= 1 / (1 + EXP((-1) * Y))

 

Probability of Extracapsular Extension

Risk for Extracapsular Extension

< 0.43

low

0.43 to 0.77

intermediate

> 0.77

high

 

NOTE: An online version of the algorithm is available at the Center for Prostate Disease Research (www.cpdr.org). In this version clinical stage T3 is included with T2b or T2c).

 


To read more or access our algorithms and calculators, please log in or register.